Compară metode
Examinează metodele selectate una lângă alta; rândurile care diferă sunt evidențiate.
| Potrivirea scorului de propensitate pentru efecte de tratament eterogene× | Potrivirea scorului de propensitate× | |
|---|---|---|
| Domeniu≠ | Inferență cauzală | Statistică pentru cercetare |
| Familie≠ | Regression model | Process / pipeline |
| Anul apariției≠ | 1983–2016 | 1983 |
| Autorul original≠ | Rosenbaum & Rubin (PSM foundation, 1983); Athey & Imbens (HTE extensions, 2016) | Paul Rosenbaum and Donald Rubin |
| Tip≠ | Causal inference / matching with effect heterogeneity | Method |
| Sursa seminală≠ | Athey, S., & Imbens, G. W. (2016). Recursive Partitioning for Heterogeneous Causal Effects. Proceedings of the National Academy of Sciences, 113(27), 7353-7360. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Denumiri alternative≠ | HTE-PSM, CATE via PSM, subgroup treatment effect matching, conditional average treatment effect matching | PSM, propensity score weighting, covariate balance |
| Înrudite≠ | 5 | 3 |
| Rezumat≠ | Heterogeneous Treatment Effect Propensity Score Matching extends standard PSM to estimate how treatment effects vary across subgroups or individual characteristics. Rather than reporting a single average treatment effect, it uses the matched sample to estimate conditional average treatment effects (CATE), revealing which types of units benefit most or least from a treatment. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateSet de date ↗ |
|
|